Literature DB >> 22237583

Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation.

Christos A Goudis1, Eleftherios M Kallergis, Panos E Vardas.   

Abstract

Atrial fibrillation is the most common arrhythmia in clinical practice and is associated with increased cardiovascular morbidity and mortality. Atrial fibrosis, a detrimental process that causes imbalance in extracellular matrix deposition and degradation, has been implicated as a substrate for atrial fibrillation, but the precise mechanisms of structural remodelling and the relationship between atrial fibrosis and atrial fibrillation are not completely understood. A large number of experimental and clinical studies have shed light on the mechanisms of atrial fibrosis at the molecular and cellular level, including interactions between matrix metalloproteinases and their endogenous tissue inhibitors, and profibrotic signals through specific molecules and mediators such as angiotensin II, transforming growth factor-β1, connective tissue growth factor, and platelet-derived growth factor. This review focuses on the mechanisms of atrial fibrosis and highlights the relationship between atrial fibrosis and atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237583     DOI: 10.1093/europace/eur398

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  26 in total

Review 1.  Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 2.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

3.  Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells.

Authors:  D Mastronicola; E Arcuri; M Arese; A Bacchi; S Mercadante; P Cardelli; G Citro; P Sarti
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

4.  Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Authors:  David R Van Wagoner; Jonathan P Piccini; Christine M Albert; Mark E Anderson; Emelia J Benjamin; Bianca Brundel; Robert M Califf; Hugh Calkins; Peng-Sheng Chen; Nipavan Chiamvimonvat; Dawood Darbar; Lee L Eckhardt; Patrick T Ellinor; Derek V Exner; Richard I Fogel; Anne M Gillis; Jeff Healey; Stefan H Hohnloser; Hooman Kamel; David A Lathrop; Gregory Y H Lip; Reena Mehra; Sanjiv M Narayan; Jeffrey Olgin; Douglas Packer; Nicholas S Peters; Dan M Roden; Heather M Ross; Robert Sheldon; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

5.  Serial measures of cardiac troponin T levels by a highly sensitive assay and incident atrial fibrillation in a prospective cohort of ambulatory older adults.

Authors:  Ayman A Hussein; Traci M Bartz; John S Gottdiener; Nona Sotoodehnia; Susan R Heckbert; Donald Lloyd-Jones; Jorge R Kizer; Robert Christenson; Oussama Wazni; Christopher deFilippi
Journal:  Heart Rhythm       Date:  2015-01-17       Impact factor: 6.343

6.  Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Derek S Chew; Eric Black-Maier; Zak Loring; Peter A Noseworthy; Douglas L Packer; Derek V Exner; Daniel B Mark; Jonathan P Piccini
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-03-19

7.  Renal function after repeat catheter ablation for long-standing persistent atrial fibrillation : Low CHA2DS2-VASc score and sinus rhythm predict improved renal function.

Authors:  Q Wang; X-D Zhang; X Liu; Y-Q Yang
Journal:  Herz       Date:  2016-01-25       Impact factor: 1.443

8.  Radiofrequency Ablation of Persistent Atrial Fibrillation: Diagnosis-to-Ablation Time, Markers of Pathways of Atrial Remodeling, and Outcomes.

Authors:  Ayman A Hussein; Walid I Saliba; Amr Barakat; Mohammed Bassiouny; Mohammed Chamsi-Pasha; Rasha Al-Bawardy; Ali Hakim; Khaldoun Tarakji; Bryan Baranowski; Daniel Cantillon; Thomas Dresing; Patrick Tchou; David O Martin; Niraj Varma; Mandeep Bhargava; Thomas Callahan; Mark Niebauer; Mohamed Kanj; Mina Chung; Andrea Natale; Bruce D Lindsay; Oussama M Wazni
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

9.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

10.  MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation.

Authors:  Meixia Zhang; Hechuan Wang; Xiaowen Wang; Mengjun Bie; Kai Lu; Hua Xiao
Journal:  Cell Cycle       Date:  2020-10-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.